MRKR
Marker Therapeutics, Inc.
Key Financials
Net Income
$-12163620
↓ 13.3%
Revenue
$0
↓ 100.0%
Operating Income
$-12890426
↓ 15.9%
Total Liabilities
$2.3M
↓ 34.4%
Total Assets
$19.1M
↓ 13.4%
Cash & Equivalents
$16.1M
↓ 16.3%
EPS (Diluted)
$-0.79
↑ 33.6%
Shareholders' Equity
$16.8M
↓ 9.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| DEFA14A | 3/20/2026 | View on SEC |
| ARS | 3/20/2026 | View on SEC |
| DEF 14A | 3/20/2026 | View on SEC |
| 8-K | 3/19/2026 | View on SEC |
| 10-K | 3/18/2026 | View on SEC |
| PRE 14A | 3/10/2026 | View on SEC |
| 8-K | 2/9/2026 | View on SEC |
| 4 | 11/19/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MRKR |
| Company Name | Marker Therapeutics, Inc. |
| CIK | 1094038 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (713) 400-6400 |